• Citer

Evaluation du coût du traitement non hormonal de l'ostéoporose.

par Peretz, Anne
Référence Revue médicale de Bruxelles, 19, 4, page (A204-A207)
Publication Publié, 1998-09

Article révisé par les pairs

• Détails
• Contenu

Résumé :

Osteoporosis is a disease affecting a large population of postmenopausal women. The treatment is given for a period of 5, 10, 20 years.... The cost of the treatment plays an important role in the field of health economy. A commercial form of calcium and vitamin D for 10 years represent for the patient a cost of 50,000 BF. The other treatments, alternative to hormonal substitution, have variable prices, for biphosphonates, 50,000 to 500,000 for the insurance and from 1,000 to 5,000 BF for the patient having a regular insurance. A comprehensive choice in long term treatment should take into account efficacy and cost of the treatment.